Ollin Biosciences

Last updated: September 23, 2025
CEO - Jason Ehrlich
CEO - Jason Ehrlich
Country: USA | Funding: $100M (+) | Add Funding

Website: https://ollin.bio/

Ollin is dedicated to advancing novel therapeutic candidates that target a broader spectrum of biology to improve outcomes for patients with severe, vision-threatening conditions.